Cardene Structural Formula (Image 01)
Cardene Iv Injection, Solution
Product Images NDC 43066-021
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardene Iv (NDC 43066-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Novaplus Symbol (Image 02)
CARDENE IL.V. e is a medication that comes in a single-dose container containing 2 mg in 200 mL of Nicardipine Hydrochloride with 0.86% Sodium Chlorde. This intravenous drug is used with caution, and it is essential to check for minute leaks before using it. The drug must not be used in a series of connections. CARDENE IL.V. e is U.S. patented and registered as a trademark. It is manufactured and marketed by Baxter Healthcare Corporation, and for any unexpected adverse reactions, contact heath care corporation.*
Representative Cardene Vizient 20 mg Container Label 43066-021-10 1 Of 2 (Image 03)
Representative Cardene Vizient 20 mg Container Label 43066-021-10 2 Of 2 (Image 04)
Representative Cardene Vizient 20 mg Carton Label 43066-021-10 1 Of 2 (Image 05)
CARDENE IV is an intravenous solution composed of Nicardipine Hydrochloride and 0.83% sodium chloride infection. It is provided in a single-dose container of 200 mL capacity. Each mL contains 0.2 mg of Nicardipine Hydrochloride in 83 mg of sodium chloride along with Hydrochloric acid and/or Sodium Hydroxide to adjust the pH. CARDENE IV should be stored in controlled room temperatures and protected from freezing and excess heat. It should not be used in series connections and must be checked for leaks before use as it may impair sterility. For more information about the dosage, see the prescribing information. Gardene is a registered trademark of Chies USA, Inc. Galaxy is a trademark of Baxter International Inc. Novaplus is a registered trademark of Vizent, Inc. If you have any suspected adverse reactions to CARDENE IV, please contact Baxter Healthcare Corporation at 19563882472.*
Representative Cardene Vizient 20 mg Carton Label 43066-021-10 2 Of 2 (Image 06)
Representative Cardene Vizient 20 mg Shipper Label 43066-021-10 1 Of 2 (Image 07)
CARDENE"LV. is a Nicardipine Hydrochloride injection used for intravenous use. It contains 40mg of Nicardipine Hydrochloride in 200mL of 0.83% Sodium Chloride Injection. It is stored in a carton until it is ready to be used, and it is packaged in a single-use container. There are warnings not to use it if there are any minute leaks, and not to add any supplements or medications. It should be stored at a controlled room temperature below 25°C and protected from light. The manufacturers of CARDENE"LV. are Baxter Healthcare Corporation.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
